Logo

Fitbit Reports Results of its COVID-19 Study for Early Detection of Diseases

Share this

Fitbit Reports Results of its COVID-19 Study for Early Detection of Diseases

Shots:

  • In May’2020- Fitbit has launched its COVID-19 study to build an algorithm that detects COVID-19 before symptoms starts. The study has enrolled 1000+ positive patients across the US and Canada is now delivering its first- preliminary results 90 days later
  • The study demonstrated that its devices could detect ~50% of COVID-19 cases one day before participants reported the onset of symptoms such as fever- cough- or muscle aches
  • The algorithm is under development and worked with 70% specificity- or a 30% rate of false positives. The study reinforces that breathing rate- resting heart rate and HRV are all useful metrics for indicating onset of illness and are best tracked at night- when the body is at rest

­ Ref: Fibit | Image: Bloomberg

Click here to­ read the full press release 

Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions